Sage Journals: Discover world-class research

Abstract

Get full access to this article

View all access options for this article.

References

Rotermann

Sanmartin

Hennessy

. Prescription medication use by Canadians aged 6 to 79. Health reports. June 2014. Available: http://www.statcan.gc.ca/pub/82-003-x/2014006/article/14032-eng.pdf (accessed Aug. 25, 2015).

Ferguson

JM.

SSRI antidepressant medications: adverse effects and tolerability. Primary Care Companion J Clin Psychiatry 2001;3:22-7.

Pitts

Kearns

AE.

Update on medications with adverse skeletal effects. Mayo Clin Proc 2011;86(4):338-43.

Liu

Anderson

Mittmann

. Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet 1998;351:1303-7.

Osteoporosis Canada. Osteoporosis facts and statistics. Available: www.osteoporosis.ca/osteoporosis-and-you/osteoporosis-facts-and-statistics/ (accessed Aug. 25, 2015).

Vochteloo

AJH

Moerman

Tuinebreijer

. More than half of hip fracture patients do not regain mobility in the first postoperative year. Geriatr Gerontol Int 2013;13:334-41.

Morin

Lix

Azimaee

. Institutionalization following incident non-traumatic fractures in community-dwelling men and women. Osteoporos Int 2012;23:2381-6.

Thapa

Gideon

Cost

. Antidepressants and the risk of falls among nursing home residents. N Engl J Med 1998;339(13):875-82.

Coupland

Dhiman

Morriss

. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ 2011;343:d4551.

10.

Warden

Robling

Sanders

. Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth. Endocrinology 2005;146(2):685-93.

11.

Schwan

Hallberg

SSRIs, bone mineral density and risk of fractures—a review. Eur Neuropsychopharmacol 2009;19(10):683-92.

12.

Chen

Hahn

Weintraub

NT.

Do SSRIs play a role in decreasing bone mineral density?

J Am Med Dir Assoc 2012;13(5):413-7.

13.

Whooley

Kip

Cauley

. Depression, falls and risk of fracture in older women. Arch Intern Med 1999;159:484-90.

14.

Mezuk

Eaton

Golden

. Depression, antidepressants and bone mineral density in a population-based cohort. J Gerontol A Biol Sci Med Sci 2008;63(12):1410-5.

15.

Bencaz

Hentz

. Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case-control studies. Osteoporos Int 2012;23(1):365-75.

16.

Eom

Lee

. Use of selective serotonin reuptake inhibitors and risk of fracture: a systematic review and meta-analysis. J Bone Miner Res 2012;27(5):1186-95.

17.

Zucker

Chodick

Grunhaus

. Adherence to treatment with selective serotonin reuptake inhibitors and the risk for fractures and bone loss. CNS Drugs 2012;26(6):537-47.

18.

Moura

Bernatsky

Abrahamowicz

. Antidepressant use and 10-year incident fracture risk: the population-based Canadian Multicentre Osteoporosis Study (CaMoS). Osteoporos Int 2014;25(5):1473-81.

19.

Wang

. Serotonergic antidepressant use and the risk of fracture: a population-based nested case–control study. Osteoporos Int 2016;27(1):57-63.

Are selective serotonin reuptake inhibitors associated with fractures?

Abstract

Get full access to this article

References